CCR 20th Anniversary Commentary: Autologous T Cells-The Ultimate Personalized Drug for the Immunotherapy of Human Cancer

被引：6
|
作者：
Rosenberg, Steven A. [1 ]
机构：
[1] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷 / 24期
关键词：
TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; RECOMBINANT INTERLEUKIN-2; ADOPTIVE IMMUNOTHERAPY; ANTIGENS; REGRESSION; THERAPY;
D O I：
10.1158/1078-0432.CCR-14-3131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The article by Rosenberg and colleagues, which was published in the July 1, 2011, issue of Clinical Cancer Research, demonstrated the power of the adoptive transfer of autologous antitumor T cells to mediate the complete, durable, and likely curative regression of cancer in patients with heavily pretreated metastatic melanoma. It also provided a stimulus to the development of cell transfer approaches for other cancer types using both natural and genetically engineered lymphocytes. (C)2015 AACR.
引用
收藏
页码：5409 / 5411
页数：3
相关论文
共 32 条
1234